Ozempic, esas olarak tip 2 diyabet hastalarnn kan ekeri dzeylerini kontrol altna almak amacyla reete edilir
The study showed no increase in the primary endpoint 4-point MACE (major adverse cardiovascular events in terms of cardiovascular death, nonfatal myocardial infarction, nonfatal cerebral stroke, unstable angina), demonstrating the cardiovascular safety of lixisenatide [5,7]
Interest in using tirzepatide for weight loss is likely to grow as more research becomes available and approval for obesity treatment may come in the future
As the Hunterbrook article predicted, the following day, the Food and Drug Administration resolved the shortage on the weight-loss drugs Mounjaro and Zepbound
In research studies, L-carnitine supplementation has been shown to have a protective effect on the liver, particularly in patients with NAFLD - non-alcoholic fatty liver diseaseand